StockVS

BlackRock Science and Technology Term Trust (BSTZ) Stock Analysis

Financial Services

BlackRock Science and Technology Term Trust

$29.40

+$0.70 (+2.44%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

BlackRock Science and Technology Term Trust functions as a closed-ended equity mutual fund launched by BlackRock, Inc., with operations managed by BlackRock Advisors, LLC. The fund invests its capital in public equity markets across the globe, specifically seeking exposure to stocks of companies operating in the science and technology sector. This entity operates within the Financial Services sector, specifically under the Asset Management industry, where it facilitates investment strategies for clients rather than generating revenue through product sales or manufacturing. The company holds a market capitalization of $1.48B, while annual revenue and employee count are not publicly disclosed in the available data. These valuation figures indicate that the fund manages a substantial pool of assets, positioning it as a significant player within the specialized asset management landscape focused on scientific and technological equities.

Financial Health

The fund reports no disclosed figures for revenue, net income, or EBITDA in the current financial reporting, which reflects the structural nature of closed-end funds where traditional operating income metrics differ from public corporations. Consequently, the gap between revenue and net income cannot be analyzed in the conventional manner used for operating companies, as the available data lists these metrics as not applicable. The fund does not report free cash flow figures, indicating that liquidity management is handled differently within the closed-end fund structure compared to public equities. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, a standard characteristic for asset management funds where expenses are deducted from the fund's assets rather than presented as traditional operational margins. The company does not disclose total cash, total debt, or a debt-to-equity ratio, meaning the balance sheet leverage profile is not quantifiable through standard corporate metrics. Similarly, the current ratio is not provided, preventing an assessment of short-term liquidity using this specific metric. Furthermore, return on equity and return on assets are listed as not applicable, which precludes a direct evaluation of management effectiveness using these specific return metrics in the standard format.

Valuation Assessment

The trailing twelve-month P/E ratio is 4.62, while the forward P/E ratio is not available for comparison. The absence of a forward P/E metric implies that future earnings trajectory expectations are not quantified through this specific valuation lens for this closed-end structure. The price-to-book ratio is not available, so the market premium over book value cannot be calculated using this standard metric. Similarly, the price-to-sales ratio and EV/EBITDA are not applicable, limiting the ability to use these alternative valuation metrics to suggest relative value against peers. The fund's share price has ranged between a 52-week low of $15.22 and a 52-week high of $23.47. To determine the current trading position relative to this range, one must observe the specific market price at any given moment, but the data confirms the historical volatility bounds within which the fund has traded. The beta value is not available, which prevents a direct comparison of the fund's price volatility relative to the broader market index.

Growth & Income

Revenue growth and earnings growth rates are not disclosed, as these metrics are typically not calculated for closed-end funds in the same manner as operating companies. Without disclosed growth rates, it is impossible to determine whether earnings are growing faster or slower than revenue, though the structural nature of the fund often decouples these traditional growth metrics from operational performance. The fund offers a dividend yield of 9.1%, which is a significant income component for shareholders. The payout ratio stands at 51.7%, indicating that the fund distributes roughly half of its distributable income to shareholders, a practice that must be evaluated against the fund's total distributable earnings to ensure sustainability. Since the fund is a closed-end structure, the distribution of earnings does not necessarily imply reinvestment into growth in the traditional sense of an open company expanding operations. The overall growth and income profile is characterized by a high current yield without the disclosure of standard growth rates or leverage metrics typically found in public corporate equity analysis.

Peer Comparison

BlackRock Science and Technology Term Trust (BSTZ) operates in the Asset Management industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
BlackRock Science and Technology Term Trust BSTZ $2.02B 6.3
BlackRock, Inc. BLK $167.25B 27.1
Blackstone Inc. BX $144.37B 30.3
Brookfield Corporation BN.TO $142.06B 89.6

The Asset Management industry average P/E ratio is 28.6x. BlackRock Science and Technology Term Trust trades at a P/E of 6.3.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About BlackRock Science and Technology Term Trust

BlackRock Science and Technology Term Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the science and technology sectors. It primarily invests in growth stocks of companies across all market capitalizations. BlackRock Science and Technology Term Trust was formed in June 2019 and is domiciled in the United States.

Visit website →

Key Statistics

Market Cap
$2.02B
P/E Ratio
6.32
52-Week High
$29.50
52-Week Low
$19.13
Avg Volume
223.70K
Dividend Yield
6.63%

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States